-+ 0.00%
-+ 0.00%
-+ 0.00%

ELOXX PHARMACEUTICALS ANNOUNCES FDA CLEARANCE OF INVESTIGATIONAL NEW DRUG APPLICATION FOR EXALUREN IN NONSENSE-MUTATION ADPKD

Reuters·10/29/2026 12:00:04

Please log in to view news